Chronic Limb-Threatening Ischemia and the Need for Revascularization
Journal of Clinical Medicine · 04.04.2023 · 12 (7) · 2682
DOI: 10.3390/jcm12072682 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.04.2023. Verfasst von Raffaella Berchiolli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients presenting with critical limb-threatening ischemia (CLTI) have been increasing in number over the years. They represent a high-risk population, especially in terms of major amputation and mortality. Despite multiple guidelines concerning their management, it continues to be challenging. Decision-making between surgical and endovascular procedures should be well established, but there is still a lack of consensus concerning the best treatment strategy. The aim of this manuscript is to offer an overview of the contemporary management of CLTI patients, with a focus on the concept that evidence-based revascularization (EBR) could help surgeons to provide more appropriate treatment, avoiding improper procedures, as well as too-high-risk ones.
Methods
We performed a search on MEDLINE, Embase, and Scopus from 1 January 1995 to 31 December 2022 and reviewed Global and ESVS Guidelines. A total of 150 articles were screened, but only those of high quality were considered and included in a narrative synthesis.
Results
Global Vascular Guidelines have improved and standardized the way to classify and manage CLTI patients with evidence-based revascularization (EBR). Nevertheless, considering that not all patients are suitable for revascularization, a key strategy could be to stratify unfit patients by considering both clinical and non-clinical risk factors, in accordance with the concept of individual residual risk for every patient. The recent BEST-CLI trial established the superiority of autologous vein bypass graft over endovascular therapy for the revascularization of CLTI patients. However, no-option CLTI patients still represent a critical issue.
Conclusions
The surgeon’s experience and skillfulness are the cornerstones of treatment and of a multidisciplinary approach. The recent BEST-CLI trial established that open surgical peripheral vascular surgery could guarantee better outcomes than the less invasive endovascular approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
ORCID-Profile: Giulia Bertagna, Francesco Canovaro, Lorenzo Torri, Nicola Troisi
Zitieren
APA
Berchiolli, R., Bertagna, G., Adami, D., Canovaro, F., Torri, L., & Troisi, N. (2023). Chronic Limb-Threatening Ischemia and the Need for Revascularization. Journal of Clinical Medicine, 12(7), 2682. https://doi.org/10.3390/jcm12072682
Vancouver
Berchiolli R, Bertagna G, Adami D, Canovaro F, Torri L, Troisi N. Chronic Limb-Threatening Ischemia and the Need for Revascularization. Journal of Clinical Medicine. 2023;12(7):2682. doi:10.3390/jcm12072682
BibTeX
@article{Berchiolli2023,
author = {Berchiolli, Raffaella and Bertagna, Giulia and Adami, Daniele and Canovaro, Francesco and Torri, Lorenzo and Troisi, Nicola},
title = {Chronic Limb-Threatening Ischemia and the Need for Revascularization},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {7},
pages = {2682},
doi = {10.3390/jcm12072682}
}
EUVIMED